Treatment of dementia with bosutinib: An open-label study of a tyrosine kinase inhibitor

2021All Articles

Nov 2

Mahdavi, K. D., Jordan, S. E., Barrows, H. R., Pravdic, M., Habelhah, B., Evans, N. E., ... & Kuhn, T. (2021). Neurology: Clinical Practice, 11(3), e294-e302.

AgingCognitive Function

Taylor Kuhn

Treatment of dementia with bosutinib: An open-label study of a tyrosine kinase inhibitor

A Case Study of Low-intensity Focused Ultrasound for Treatment-Resistant Generalized Anxiety Disorder and Major Depressive Disorder

A case of COVID-encephalopathy imaged with fMRI and treated with near infrared light